| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/28/2008 | US20080206890 Bis(2,9-di-tert-butyl-1,10-phenanthroline)copper(i) complexes, methods of synthesis, and uses therof |
| 08/28/2008 | US20080206889 Comparative multiple analyte assay |
| 08/28/2008 | US20080206888 bound chemical entities are exposed to radiation at an excitation frequency for either the first or the second fluorophore, and polarization anisotropy of a FRET fluorescent signal from the bound chemical entities is measured to detect specific binding between the first and second chemical entities |
| 08/28/2008 | US20080206881 measurement of the serum protein carbonyl content allows a quantitative and early diagnosis of these diseases |
| 08/28/2008 | US20080206880 Determining a coagulation time, e.g., thrombin, prothrombin, partial thromboplastin, or activated clotting times, using a test cartridge with agitator vane leaflets that can be swept through the test sample in the absence of coagulation; resistance to agitator movement due to coagulation is detected |
| 08/28/2008 | US20080206876 selective and direct detection of free metals in fluids and methods to diagnose metal-related diseases and determine pharmacologic dosing regimens |
| 08/28/2008 | US20080206863 embryonic stem cell having been genetically engineered with DNA which encodes MyoD, which promotes differentiation of said embryonic stem cell into a muscle cell |
| 08/28/2008 | US20080206855 automated liquid handler to aspirate samples from the sample plate and to dispense each of these samples directly onto the assay in the permeable media |
| 08/28/2008 | US20080206853 Signal enhancement system with multiple labeled-moieties |
| 08/28/2008 | US20080206849 lateral flow assay device; for identifying carbohydrate antigens in a biological sample comprises a substrate having, a sample receiving zone, an extraction zone |
| 08/28/2008 | US20080206838 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 08/28/2008 | US20080206797 determination of the procalcitonin immunoreactivity is carried out in a sample of the cerebrospinal fluid of a patient who is suffering from a dementia or neuroinflammatory disease; severity or success of treatment are drawn from a measured immunoreactivity which is above a threshold value |
| 08/28/2008 | US20080206796 Use of the Salivary Protein Cd14 as an Indicator of the Low Risk to Developing Dental Caries |
| 08/28/2008 | US20080206795 Novel Supports, in Particular for Immunodetection of Molecules of Interest |
| 08/28/2008 | US20080206794 Systems And Methods For Characterizing Contrast Induced-Nephropathy |
| 08/28/2008 | US20080206793 based on the discovery that levels of circulating cerebral NMDA receptor peptides and antibodies can be used to identify patients who are likely to suffer from an adverse neurological event |
| 08/28/2008 | US20080206792 identifying agents that inhibit ROS by altering the binding of a GTPase such as Rac to SOD, agents identified by the method, and methods of using compounds that inhibit ROS to inhibit or treat neuronal degenerative diseases |
| 08/28/2008 | US20080206791 adding a plurality of immuno-beads to a test substance; exposing a crystal microbalance immunosensor to the first sample; determining a change in a first motional resistance of the crystal microbalance immunosensor following exposure to the first sample ( Delta R1) |
| 08/28/2008 | US20080206790 Assay for determining the presence or amount of newly synthesized antibodies |
| 08/28/2008 | US20080206789 Method of Screening Mhc Molecules |
| 08/28/2008 | US20080206788 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 08/28/2008 | US20080206787 contacting a blood component with a substrate comprising a cleavage site of the enzyme and a tag moiety to produce a sample comprising a cleavage product having a known mass, and placing the sample in contact with a SELDI sample chip which has surface moieties which bind to the cleavage product |
| 08/28/2008 | US20080206786 Trace amine receptor 1 of the african green monkey |
| 08/28/2008 | US20080206785 Using voltage sensitive dyes to identifying modulators of G-protein sensory signaling; immunoassay; customizing taste of foods and/or medicines |
| 08/28/2008 | US20080206784 base consisting of a soluble protein; and two or more functional domains capable of binding to different target substances |
| 08/28/2008 | US20080206782 Methods for Determining the Bivalency of Protein and Antibody Therapeutics |
| 08/28/2008 | US20080206781 in addition to a fluorescent drug efflux probe as an indicator of MDR protein activity, the instant assays provide an o-tolidine-based dye for quenching extracellular fluorescence of the probe |
| 08/28/2008 | US20080206780 plurality of antibody fragments, each comprising a framework region having a murine VH14 heavy chain and a murine VK2 light chain, or homologues thereof, each antibody fragment further comprising at least one different CDR; immobilised on a support material |
| 08/28/2008 | US20080206777 indicative of whether patient afflicted with non-small cell lung cancer is responsive to treatment with an EGFR-TK inhibitor; p70S6K, phospho-p70S6, phospho-S6, phospho-AKT, phospho-mTOR, phospho-pTEN, phospho MEK, phospho MAPK, phospho-IGFR/InR, EGFR, phosho-EGFR, phospho-HER2 (ErbB2), phospho-ER, etc. |
| 08/28/2008 | US20080206774 Automated cancer diagnostic methods using fish |
| 08/28/2008 | US20080206764 Flowcell system for single molecule detection |
| 08/28/2008 | US20080206763 Partitioning endogenous cellular transcription products and associated proteins for generating gene expression profile of cells |
| 08/28/2008 | US20080206762 determining the expression level of a gene encoding a lysosomal marker; marker is preferably Lamp-1 or Lamp-2 |
| 08/28/2008 | US20080206757 Methods and compositions for detecting rare cells from a biological sample |
| 08/28/2008 | US20080206745 Nucleotide squences extraction solution; for use recovering preferential nucleic acids |
| 08/28/2008 | US20080206737 Expression quantification using mass spectrometry |
| 08/28/2008 | US20080206357 VIF as a traget for HIV inhibition |
| 08/28/2008 | US20080206289 identifying a human subject as a candidate for prostate cancer examination by determining whether the human has developed an immune reaction to a prostate cancer antigen; drug screening |
| 08/28/2008 | US20080206284 E. coli heat-labile enterotoxin that binds to GM1 ganglioside receptors; allergic rhinitis |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206264 when bound by a highly potent human neutralizing monoclonal antibody specific for a V3 conformational epitope; immunogens for inducing broadly-neutralizing antibodies against HIV-1 as well as antagonists for inhibiting the binding of HIV-1 to the relevant co-receptors |
| 08/28/2008 | US20080206261 administering RegIII protein or Ins2 protein; expression of the IBD marker was decreased |
| 08/28/2008 | US20080206256 Treatments for cancer |
| 08/28/2008 | US20080206254 human monoclonal antibody of the IgG isotype; preventing and treating cardiovascular disorders; specifically binds to the A2 domain of FVIII |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206248 associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and for the prediction of the efficacy of anti-ErbB2 therapy in cancer patients; insertion mutations as well as point mutations |
| 08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206236 Polyclonal antibody product |
| 08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206232 Compositions and Methods For Modulating Pgc-1Beta to Treat Lipid-Related Diseases and Disorders |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206198 Using epithelial sodium channel (ENaC) inhibitor to treat and prevent nervous system and lung disorders |
| 08/28/2008 | US20080206144 Identification of a truncation polymorphism of the mdr1 gene that is linked to ivermectin sensitivity in subjects such as collie dogs; use in bioassay testing to see which drugs certain canines will have adverse reactions to; pharmacogenetics |
| 08/28/2008 | US20080206143 Blockade of Elr+Cxc Chemokines as a Treatment For Inflammatory and Autoimmune Disease |
| 08/28/2008 | US20080206140 Antibodies specific to malignant cancer specific proliferating cell nuclear antigen (csPCNA) and not to the non-malignant proliferating cell nuclear antigen (nmPCNA) isoform; cancer diagnosis, prognosis, tumor detection and therapy; immunoassay kit |
| 08/28/2008 | US20080206133 Patient-specific anticancer monoclonal antibodies for staging and diagnosis of a cancer, treating tumors and metastases; monoclonal antibody produced by hybridoma; conjugates with cytotoxic agents for tissue-targeted therapy |
| 08/28/2008 | US20080206132 Cancerous Disease Modifying Antibodies |
| 08/28/2008 | US20080205506 Method for determining the likelihood of a match between source data and reference data |
| 08/28/2008 | US20080204733 Sensing in Meat Products and the Like |
| 08/28/2008 | US20080204429 Controller Arrangement For An Optical Sensing Pen |
| 08/28/2008 | US20080204043 Real-Time Assessment of Biomarkers for Disease |
| 08/28/2008 | US20080203502 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 08/28/2008 | US20080203291 Ion detection using a pillar chip |
| 08/28/2008 | US20080202928 Multi-layer strip for use in measuring biological material and system for measuring biological material |
| 08/28/2008 | US20080202217 Dual Sample Cartridge and Method for Characterizing Particles in Liquid |
| 08/28/2008 | US20080202216 System and Method for Monitoring and/or Controlling Attributes of Multiple Chemical Mixtures with a Single Sensor |
| 08/28/2008 | US20080202215 Pressurized crystallization point automated test apparatus |
| 08/28/2008 | US20080202214 Crystallization point automated test apparatus |
| 08/28/2008 | US20080202207 Sorbent trap cartridge for mercury emissions monitoring |
| 08/28/2008 | US20080202195 GOLD NANOPARTICLE-BASED pH SENSOR IN HIGHLY ALKALINE REGION BY SURFACE-ENHANCED RAMAN SCATTERING STUDY |
| 08/28/2008 | DE102007009784A1 Device for evaluating test sample, particularly medical test sample, has radiation source for generating electromagnetic radiation, measuring instrument for measuring reflected radiation from test sample and evaluator |
| 08/28/2008 | DE102007009565A1 Method for determining fuel composition in injection system of internal-combustion engine particularly of motor vehicle, involves determining physical parameter assigned to fuel pressure wave |
| 08/28/2008 | DE102005059536B4 Verfahren und Biochip zur Untersuchung einer biologischen Probe Methods and biochip for assaying a biological sample |
| 08/28/2008 | CA2684897A1 Prostate cancer survival and recurrence |
| 08/28/2008 | CA2679602A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene |
| 08/28/2008 | CA2679090A1 Brewing apparatus and method |
| 08/28/2008 | CA2678870A1 Human pancreatic beta cell lines for diagnostic of diabetes |
| 08/28/2008 | CA2678757A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | CA2678755A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | CA2678493A1 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 08/28/2008 | CA2678401A1 Process for purification of water soluble polymers |
| 08/28/2008 | CA2678199A1 Method of identifying risk for thyroid disorder |
| 08/28/2008 | CA2675267A1 Method for producing resin molding |
| 08/28/2008 | CA2670134A1 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications |
| 08/27/2008 | EP1962097A1 Mass spectrometric quantitative detection of methyl malonic acid and succinic acid using hilic on a zwitterionic stationary phase |
| 08/27/2008 | EP1962096A2 SCD40L, PAPP-A, and placental growth factor (PIGF) as biochemical marker combination for cardiovascular diseases |
| 08/27/2008 | EP1962095A1 Method for increasing light emission from a chemiluminescent reaction |
| 08/27/2008 | EP1962094A1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 08/27/2008 | EP1962093A1 Analyzer and analysis method |
| 08/27/2008 | EP1962092A2 Systems and methods for characterizing kidney diseases |
| 08/27/2008 | EP1962091A1 Methods and kits for detecting and measuring ADAMTS13/FX1 complexes |
| 08/27/2008 | EP1962090A1 Method for evaluating or screening hair growth-regulating agent |
| 08/27/2008 | EP1962089A1 Expendable launchable probe for temperature and fluorescence measurements of the undersea environment |
| 08/27/2008 | EP1962078A1 Method and apparatus for optical rotating power measurement |
| 08/27/2008 | EP1961824A1 Monitoring of intracellular mitochondrial localization |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961818A2 Novel fetal genes |